| Date Filed | Type | Description |
| 06/30/2023 |
4
| THEUER CHARLES (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 05/25/2023 |
4
| THEUER CHARLES (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $17.98, valued at
$404.6k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 200 shares
@ $1.52, valued at
$304
Bought 4,800 shares
@ $1.52, valued at
$7.3k
|
|
| 02/03/2023 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 332,000 options to buy
@ $1.7, valued at
$564.4k
|
|
| 01/19/2023 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 6,800 shares
@ $1.62, valued at
$11k
|
|
| 12/15/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 23,000 shares
@ $1.2937, valued at
$29.8k
|
|
| 11/22/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 13,900 shares
@ $1.41, valued at
$19.6k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $1.77, valued at
$8.9k
|
|
| 10/05/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $1.67, valued at
$8.4k
|
|
| 09/26/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $1.76, valued at
$8.8k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| THEUER CHARLES (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $7.77, valued at
$174.8k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 4,500 shares
@ $2.3, valued at
$10.4k
|
|
| 04/12/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 2,000 shares
@ $2.5, valued at
$5k
|
|
| 04/01/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 4,000 shares
@ $2.7, valued at
$10.8k
|
|
| 03/23/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 1,200 shares
@ $2.45, valued at
$2.9k
|
|
| 02/01/2022 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 265,000 options to buy
@ $2.32, valued at
$614.8k
|
|
| 11/22/2021 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 681 shares
@ $2.88, valued at
$2k
Bought 3,500 shares
@ $2.82, valued at
$9.9k
|
|
| 11/09/2021 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $3.41, valued at
$3.4k
Bought 3,000 shares
@ $3.415, valued at
$10.2k
|
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 11,000 shares
@ $8.9792, valued at
$98.8k
|
|
| 12/30/2020 |
4
| THEUER CHARLES (President and CEO) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $9.98, valued at
$10k
|
|
| 12/10/2020 |
3
| THEUER CHARLES (Director) has filed a Form 3 on 4D Molecular Therapeutics Inc. |
|